Biological Drugs Market: Global Industry Analysis, Trends, Market Size & Forecasts up to 2023

1
Biological Drugs Market Global Industry
Analysis, Trends, Market Size Forecasts up to
2023
2
The report on Biological Drugs Market by roduct
Type (therapeutic protein -levemir, neulasta,
eylea, novolog, enbrel, avonex, neupogen,
humalog, victoza, lantus, epogen, aranesp
monoclonal antibody - avastin, humira, remicade
vaccine - gardasil, prenvar 13, fluzone) trends
analysis and forecasts up to 2023 studies the
market sizes, key trends and opportunities in
the main geographies such as North America,
Europe, Asia-Pacific, Rest of the World.
According to the report the Global Biological
Drugs Market is projected to grow at a CAGR
between 10.0 to 10.5 in terms of value over the
period of 2017-2023. The growth in the world
market is primarily driven by significant
contribution by North America (Leading region)
region to this market. Increasing geriatric
population in the world is driving the growth of
the biological drugs market, as there is
increasing requirement for effective medicines
for various illnesses affecting old age people.
Increasing number of patients with cancer,
diabetes and other major chronic illnesses are
expected to drive the growth of the biological
drugs market during the forecast period.
Biological drugs are more effective than
respective chemical and other alternative
medicines for several complex chronic illnesses.
Hence, the biological drugs market is
anticipated to attain significant growth in
demand, despite the high cost of the products.
The investments in research and development of
biological drugs and innovation in manufacturing
of biologics are anticipated to yield more
products during the forecast period. Moreover,
the promotional activities by various health
organisations and policies by governments to make
biological drugs affordable for the treatment of
chronic illnesses are expected to enhance the
growth of the global biological drugs market.
Furthermore, the health regulatory policies with
restrictions on chemical drugs with severe side
effects and the improving healthcare services in
various countries are expected to enhance the
growth of the global biological drugs
market. The expiry of patents of many biological
drugs provides opportunity for low cost
biosimilars and other biological pharmaceutical
companies to manufacture alternative drugs.
Higher cost of manufacturing and the higher
selling price of biological drugs give
biosimilars and other alternatives the price
advantage. Severe side effects related to
injectable type of biological drugs is a
restraint to the expansion of the market. The
complexity of manufacturing of biological drugs
is a major challenge for the global biological
manufacturers,
3
especially in the developing and least developed
countries, where it is difficult to maintain both
the controlled environment for manufacturing and
quality control. Moreover, lack of proper
refrigeration or environment controllable
transportation facilities hinder the uniform
quality of biological drugs in different
regions, due to contamination at different
stages. However, the need for effective medicines
for illnesses like cancer, autoimmune diseases,
and other chronic illnesses with minimal side
effects when compared to chemical drugs is
expected to provide opportunities for major
players in the biological drugs market during
the forecast period. Get Sample Copy of this
Report- https//www.infiniumglobalresearch.com/R
eports/MakeSampleRequest/15 Segments
Covered The report segments the global
biological drugs market by product and region. On
the basis of product, the market is segmented as
protein therapy, mAb therapy and vaccines.
Monoclonal antibodies segment is expected to
sustain a major share in the global biological
drugs market during the forecast period.
Among protein therapy segment, Enbrel is expected
to attain more demand with fastest growth rate
during the forecast period. Among the vaccines,
the demand for Prevnar 13 is anticipated to grow
significantly during the forecast
period. Geographic Coverage and Analysis The
report provides regional analysis covering
geographies such as North America, Europe,
Asia-Pacific, and Rest of the World. North
America dominates the global biological drugs
market with a major share. Increasing technologica
l advancements, favorable regulatory policies and
increasing awareness about the biological due to
intervention of governments and other agencies
are the major factors that drive the growth of
the North American biological drugs market.
Moreover, the increasing demand for biological
drugs for the treatment of chronic illnesses
such as cancer and diabetes is anticipated to
drive the growth of the North American
biological market during the forecast period.
4
The presence of large geriatric population in the
countries such as Germany and United Kingdom
drive the growth of European biological drugs
market. Furthermore, presence of top quality
research and development infrastructure due to
the partnerships between research institutes and
manufacturing companies and increased funding
from private-public initiatives drives the growth
of the European market. The demand for
alternative drugs for the treatment of chronic
illnesses from the emerging nations in the
Eastern Europe is anticipated to enhance the
growth of the European biological drugs
market. Presence of large population with chronic
illnesses, initiatives from governments to
promote biologics, high investments in biologic
drug manufacturing facilities, encouragement for
biotech companies and research initiatives are
major factors that drive the Asian biological
drugs market. Moreover, the low manufacturing
cost and the availability of low cost labor is
expected to enhance the growth of the Asian
biological drugs market, as it could attract
more established players in the global market to
Asia. The presence of good regulatory frameworks
for biologics, increasing instances of chronical
illnesses and encouragement from governments to
promote manufacturing of drugs to in the region
to make treatments affordable are the major
factors that drive the Latin American biological
drugs market. Substandard biological drugs due to
the absence of stringent regulatory frameworks,
presence of biosimilars and other alternatives
are the major restraints for African biological
drugs market. However, with the Ebola outbreak in
recent past and the presence of large number of
patients with AIDS and other chronic illnesses
provide positive outlook for the growth of the
biological drugs market in Africa. Presence of
numerous patients with diabetes, rheumatoid
arthritis and other chronic illnesses and
availability of good healthcare systems are
expected to drive the biological drugs market in
the Middle East during the forecast period. Make
an Enquiry- https//www.infiniumglobalresearch.c
om/Reports/MakeEnquiryRequest/15
5
Companies Profiled AbbVie Inc, Amgen
Inc, Bristol-Myers Squibb, Biogen
Idec, Hoffman-La Roche AG, Johnson Johnson,
Lilly, Merck Co Inc, Novartis , Novo Nordisk
, Pfizer Inc, Sanofi SA.
6
Click the Below Full Report Link-
https//www.infiniumglobalresearch.com/healthcare_
medical_devices/biological_drugs_market Report
Highlights The report provides deep insights on
demand forecasts, market trends and micro and
macro indicators. In addition, this report
provides insights on the factors that are driving
and restraining the demand of biological drugs
globally as well as regionally. Moreover,
IGR-Growth Matrix analysis given in the report
brings an insight on the investment areas that
existing or new market players can consider. The
report provides insights into the market using
analytical tools such as Porters five forces
analysis and value chain analysis of biological
drugs. Moreover, the study highlights current
market trends and provides forecast from 2017 to
2023. We also have highlighted future trends in
the biological drugs market that will impact the
demand during the forecast period. Moreover, the
competitive analysis given in each regional
market brings an insight on the market share of
the leading players. Additionally, the analysis
highlights rise and fall in the market shares of
the key players in the market. This report will
help manufacturers, suppliers and distributors of
the biological drugs market to understand the
present and future trends in this market and
formulate their strategies accordingly.